Literature DB >> 14022524

Isoniazid prophylaxis in an undeveloped area.

G W COMSTOCK.   

Abstract

Entities:  

Keywords:  ISONIAZID; TUBERCULOSIS

Mesh：

Substances：

Year:  1962        PMID： 14022524     DOI： 10.1164/arrd.1962.86.6.810

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  19 in total

1.  Antituberculous therapy in pregnancy. Risks to the fetus.

Authors:  D J Scheinhorn; V A Angelillo
Journal:  West J Med       Date:  1977-09

2.  A brief history of the cluster randomised trial design.

Authors:  Jenny Moberg; Michael Kramer
Journal:  J R Soc Med       Date:  2015-05       Impact factor: 5.344

3.  Results of 20 years of tuberculosis control in Alaska.

Authors:  M W Johnson
Journal:  Health Serv Rep       Date:  1973-03

4.  Community isoniazid prophylaxis program in an underdeveloped area of Alaska.

Authors:  M L Hanson; G W Comstock; C E Haley
Journal:  Public Health Rep       Date:  1967-12       Impact factor: 2.792

5.  Epidemiological basis of tuberculosis eradication. 4. The isoniazid trial in Greenland.

Authors:  O Horwitz; P G Payne; E Wilbek
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

6.  A program for tuberculosis control in the schools.

Authors:  G D Hanzel
Journal:  Am J Public Health Nations Health       Date:  1970-07

7.  Planning models for tuberculosis control programs.

Authors:  R W Chorba; J L Sanders
Journal:  Health Serv Res       Date:  1971       Impact factor: 3.402

8.  Feasibility of a chemoprophylaxis trial in India against tuberculosis. A pilot study.

Authors:  R Narain; S Mayurnath; M S Rao; S S Murthy
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

9.  The use of isoniazid among household contacts of open cases of pulmonary tuberculosis.

Authors:  T Egsmose; J O Ang'awa; S J Poti
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

10.  Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules.

Authors:  Stanzi M le Roux; Mark F Cotton; Jonathan E Golub; David M le Roux; Lesley Workman; Heather J Zar
Journal:  BMC Med       Date:  2009-11-03       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.